Institute of Liver and Digestive Health, Royal Free Hospital, London, UK.
Liver Int. 2013 Mar;33(3):398-409. doi: 10.1111/liv.12047.
Patients with cirrhosis frequently develop renal dysfunction, a proportion of who do not fulfill criteria for hepatorenal syndrome (HRS). We hypothesized that the kidneys in these patients would exhibit histological and biomarker evidence of kidney injury. We looked specifically for TLR expression as they may mediate kidney injury.
Sixty seven subjects (6); alcoholic cirrhosis: compensated (9), acute deterioration of alcoholic cirrhosis (52)] were included. Renal dysfunction was defined as a creatinine of >133 μmol/L and/or according to the AKI network criteria. Urinary biomarkers, KIM-1, πGST, αGST and a novel biomarker, urinary TLR4 were measured. Renal biopsies were also available from eight other alcoholic cirrhosis patients (three non-HRS renal dysfunction; five HRS) that were stained for TLR4 and caspase-3.
Fourteen patients developed renal dysfunction, amongst these three had type 2 HRS. KIM-1, πGST and αGST were higher in patients with acute deterioration of cirrhosis compared with patients with compensated cirrhosis, but did not differ between those with and without renal dysfunction. Urinary TLR4 was significantly higher in patients with renal dysfunction associated with infection/inflammation. Kidney biopsies from non-HRS renal dysfunction patients showed tubular damage with evidence of increased tubular expression of TLR4, and caspase-3. Minor changes were observed in HRS patients.
The data provide proof of concept that renal dysfunction in patients with cirrhosis with superimposed inflammation is associated with significant tubular injury and apoptosis and with increased renal expression and urinary excretion of the TLR4, suggesting a potential role of TLR4 as mediator of renal injury.
肝硬化患者常发生肾功能障碍,其中一部分不符合肝肾综合征(HRS)的标准。我们假设这些患者的肾脏会出现组织学和生物标志物证据的肾损伤。我们特别寻找 TLR 表达,因为它们可能介导肾脏损伤。
共纳入 67 例患者(6 例);酒精性肝硬化:代偿期(9 例),急性酒精性肝硬化恶化(52 例)。肾功能障碍定义为肌酐>133 μmol/L 和/或根据 AKI 网络标准。测量尿生物标志物、KIM-1、πGST、αGST 和一种新的生物标志物尿 TLR4。还从另外 8 例酒精性肝硬化患者(3 例非 HRS 肾功能障碍;5 例 HRS)获得肾脏活检,这些患者的 TLR4 和 caspase-3 染色。
14 例患者出现肾功能障碍,其中 3 例为 2 型 HRS。与代偿性肝硬化患者相比,急性恶化的肝硬化患者的 KIM-1、πGST 和αGST 更高,但肾功能障碍患者与无肾功能障碍患者之间无差异。与感染/炎症相关的肾功能障碍患者的尿 TLR4 明显升高。非 HRS 肾功能障碍患者的肾脏活检显示肾小管损伤,并伴有 TLR4 和 caspase-3 表达增加。在 HRS 患者中观察到轻微变化。
数据提供了概念验证,即肝硬化伴炎症加重的患者的肾功能障碍与显著的肾小管损伤和细胞凋亡以及肾脏 TLR4 的表达和尿排泄增加有关,提示 TLR4 可能作为肾脏损伤的介质。